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This third edition of this special issue focused on the interre-
lationships between metabolic pathways, metabolites, and
the immune system. Chronic low-grade inflammation is a
common phenotype found in several diseases including obe-
sity, cancer, type 2 diabetes, and cardiovascular diseases,
directly participating in their development, as well as a con-
necting factor between them. Evidence accumulated over
the years has shed light on the important role of dysregulated
metabolic pathways caused by nutrient excess, lipid overload,
sedentary behaviour, and aging as promoting factors and
modulators of inflammation. Immune cells through the
secretion of cytokines and other inflammatory mediators,
on the other hand, also modulate insulin signalling, glucose,
and lipid metabolism.
This special issue received the submission of 20 manu-
scripts focused on different aspects of the intricate relation-
ship between the immune system and metabolism; among
which, 9 were accepted for publication. Three of these articles
provide insightful reviews of the literature within the scope of
this issue. Yamashita and colleagues, for example, reviewed
the molecular mechanisms by which chronic exposure to
excessive amounts of the nutrient lipids, glucose, and amino
acids regulates inflammatory pathways, with a special
emphasis in the role of the nutrient and energy sensors
mTOR, AMPK, and PPARs in this context. Belizário and
colleagues, on the other hand, reviewed the emerging role
of microbiota as a major factor in the development of chronic
inflammatory diseases. This timely review article, among
other aspects, discussed the role of dysbiosis as the trigger
of inflammation in different pathological conditions and
the possibility of management of microbiota as a nonphar-
macological intervention to counteract disease development.
Finally, Brinchmann and colleagues elegantly revisited the
role of galectins, β-galcotosid-binding lectin found in the
intra- and extracellular compartments, in the regulation of
metabolism and inflammation and as possible targets to treat
chronic diseases.
In addition to review articles, this special issue also pub-
lished 6 interesting original studies. Among them, 4
described possible beneficial effects of anti-inflammatory
strategies to counteract disease development. Lin et al., for
example, demonstrate that shock wave therapy induces mito-
chondrial delivery to lung parenchyma and, by reducing
alveolar macrophage infiltration and fibrosis, protects from
acute respiratory distress syndrome. In another original
study, Qian et al. robustly showed that osthole, a natural cou-
marin extract, reduces inflammation and the production of
proinflammatory cytokines by macrophages increasing mice
survival to septic shock. In the same direction, Samblas and
colleagues elegantly demonstrate that folic acid, a naturally
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occurring dietary component of the methionine pathway for
the synthesis of S-adenosyl methionine (SAM), the universal
methyl-donor for DNA methylation, reduces the production
and secretion of the proinflammatory cytokines TNF-α and
IL-1β induced by LPS in macrophages. Finally, Wang et al.
showed that inhibition of the histone deacetylase HDAC2
with CAY10683 protected rats from LPS-induced acute liver
failure and endotoxemia by improving the integrity of the
intestinal barrier and reducing the activation of the
LPS-TLR4-MYD-88 pathway.
Noteworthy, two original studies of this special issue have
evaluated the changes in the metabolic profile of immune
cells in different conditions. Ahmed and colleagues demon-
strate through transcriptional profile dataset that treatment
of human and mice macrophages with interferon- (IFN-) α
promotes important changes in their metabolic signature
characterized by activation of pathways involved in cellular
bioenergetics, cellular oxidant status, cAMP/AMP and
cGMP/GMP ratios, branched chain amino acid catabolism,
cell membrane composition, fatty acid synthesis, and β-oxi-
dation. Finally, Santarsiero and colleagues elegantly showed
that patients with Behçet’s syndrome (BS), a multisystemic
disorder characterized by chronic inflammation and vasculi-
tis, displayed elevated mRNA levels of the mitochondrial
citrate carrier (SLC25A1) and ATP-citrate lyase (ACLY) in
peripheral blood mononuclear cells (PBMCs) suggesting a
dysregulation of citrate metabolism that could participate
in the increased proinflammatory response displayed by
these cells.
Altogether, the studies published in this special issue
bring new insights into the intricate mechanisms driving
the inflammatory processes associated with metabolic dis-
eases. We hope that these studies will pave the way for the
development of novel efficient strategies to prevent and treat
these increasingly common conditions.
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